He was life-flighted to Bern but still needs to travel back to the U.S. — but he already owes hundreds of thousands in ...

NT219, a novel agent designed to overcome tumor resistance to drug therapy, will be evaluated in combination with the standard-of-care head and ...

The Company expects to receive aggregate gross proceeds of US$8 million from the Offering, before deducting underwriting discounts and other related expenses. The Offering is expected to close on or ...

What you should knowA 4-alarm fire broke out shortly after 9:30 p.m. Monday at SPS Technologies, an aerospace parts supplier in Montgomery County.No injuries were reported as of Tuesday morning, and ...

NeuroPace expects to use approximately $49.5 million of the net proceeds from the offering to repurchase 5,270,845 shares of the Company's common stock held by NeuroPace's significant stockholder, KCK ...

Kiromic BioPharma, Inc. ("Kiromic" or the "Company") reports continued favorable efficacy results from the 10-month follow-up visit for the fourth patient enrolled in its Deltacel-01 Phase 1 clinical ...

Mervyn Eyre, chief executive officer of Fujitsu Caribbean, told the Jamaica Observer in an interview that Jamaica was a prime ...

Level 5: Organizations, AI that can do the work of an organization ...

NT219, a novel agent designed to overcome tumor resistance to drug therapy, will be evaluated in combination with the standard-of-care head and neck cancer drugs pembrolizumab (Keytruda) or cetuximab ...

Detailed price information for Coda Octopus Group (CODA-Q) from The Globe and Mail including charting and trades.

The Industrial Technology Research Institute (ITRI) is proud to exhibit its innovative drone technologies at XPONENTIAL ...